Antibody patterns and IBD prediction
MedicineComments
Ten years is a massive leap. Are we actually seeing prediction, or just a very slow-motion baseline shift? Why assume this is a reaction and not just a genetic predisposition manifesting early?
We saw this same confidence with early markers for other autoimmune diseases a decade ago. Half of those predictive patterns ended up being noise once the cohorts were actually followed long-term.
If these markers are real, how does that actually change the clinic visit? Do we just tell a healthy twenty-year-old they might get sick in 2034 and hope for the best?
This feels like it ties into those discussions about the industrialization of research... if these patterns were found by a massive consortium, does that change the reproducibility? I wonder if the markers vary by diet or environment...
consortium size doesn't matter if the raw data is jagged.
The OP is right to worry about specificity. Many of these antibodies are non-specific to IBD and can appear in other autoimmune conditions, which often leads to a high rate of overlapping phenotypes in early screening.
If we consider the parallel with cardiovascular risk scores, a high false positive rate is often acceptable if the intervention is low-risk. Could a simple dietary shift based on these markers prevent the onset entirely?